Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

296.60
Delayed Data
As of 4:00pm ET
 -5.21 / -1.73%
Today’s Change
281.89
Today|||52-Week Range
543.55
-21.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues1.5B1.5B1.6B1.5B
 
 
 
 
 
Cost of Goods Sold102.9M104.2M105.7M114.9M
 
 
 
 
 
Depreciation And Amortization35.1M37.7M34.5M36.4M
 
 
 
 
 
 
Operating ExpensesGross Income1.3B1.4B1.4B1.4B
 
 
 
 
 
General Expenses781.8M798.8M903.4M793.0M
 
 
 
 
 
Research And Development474.8M492.0M493.5M462.2M
 
 
 
 
 
Total Operating Expenses919.8M940.7M1.0B944.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income550.3M559.9M538.8M567.2M
 
 
 
 
 
Extraordinary Credit0.000.00--9.4M
 
 
Extraordinary Charge-30.1M0.00--0.00
 
 
Interest Expense On Debt5.4M6.2M6.0M6.4M
 
 
 
 
 
Other Expenses11.0M11.9M22.0M15.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income525.9M565.6M554.8M585.4M
 
 
 
 
 
Income Taxes-138.1M-177.3M-381.2M-107.4M
 
 
 
 
 
Net Income387.7M388.3M173.5M478.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS106.0M106.7M107.0M107.6M
 
 
 
 
 
Shares To Calculate EPS Diluted116.1M117.0M115.9M114.9M
 
 
 
 
 
 
Earnings Per ShareEPS$3.34$3.32$1.50$4.16
 
 
 
 
 
EPS Diluted$3.34$3.32$1.50$4.16